Published March 2012 | Version v1
Journal article

The importance of bystander effects in radiation therapy in melanoma skin-cancer cells and umbilical-cord stromal stem cells

  • 1. Hospital Universitario Virgen de la Victoria, Unidad de Gestión Clínica de Oncología, Málaga (Spain)
  • 2. Instituto Butantan, Centro de Pesquisa e Formação em Imunologia, São Paulo (Brazil)
  • 3. Instituto de Biopatología y Medicina Regenerativa, Universidad de Granada (Spain)
  • 4. Instituto de Parasitología y Biomedicina López-Neyra, Granada (Spain)
  • 5. Hospital Universitario San Cecilio, Granada (Spain)

Description

Purpose: To examine direct and bystander radiation-induced effects in normal umbilical-cord stromal stem cell (HCSSC) lines and in human cancer cells. Materials and methods: The UCSSC lines used in this study were obtained in our laboratory. Two cell lines (UCSSC 35 and UCSSC 37) and two human melanoma skin-cancer cells (A375 and G361) were exposed to ionizing radiation to measure acute radiation-dosage cell-survival curves and radiation-induced bystander cell-death response. Normal cells, although extremely sensitive to ionizing radiation, were resistant to the bystander effect whilst tumor cells were sensitive to irradiated cell-conditioned media, showing a dose–response relationship that became saturated at relatively low doses. We applied a biophysical model to describe bystander cell-death through the binding of a ligand to the cells. This model allowed us to calculate the maximum cell death (χmax) produced by the bystander effect together with its association constant (KBy) in terms of dose equivalence (Gy). The values obtained for KBy in A375 and G361 cells were 0.23 and 0.29 Gy, respectively. Conclusion: Our findings help to understand how anticancer therapy could have an additional decisive effect in that the response of sub-lethally hit tumor cells to damage might be required for therapy to be successful because the survival of cells communicating with irradiated cells is reduced.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2011.11.002

Additional details

Identifiers

DOI
10.1016/j.radonc.2011.11.002;
PII
S0167-8140(11)00643-8;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
102
Journal Issue
3
Journal Page Range
p. 450-458
ISSN
0167-8140
CODEN
RAONDT

Optional Information

Copyright
Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.